Concepedia

Richard B. Toupence

RB

7

Publications

255

Citations

7

H-Index

2000

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Richard B. Toupence is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

2000–2010

7

Publications

7

A convergent synthesis of ( S )-β-methyl-2-aryltryptamine based gonadotropin releasing hormone antagonists

Thomas F. Walsh, Richard B. Toupence, Feroze Ujjainwalla et al. · Tetrahedron · 2001 · 73 citations

, , +6

Potent antagonists of gonadotropin releasing hormone receptors derived from quinolone-6-carboxamides

Thomas F. Walsh, Richard B. Toupence, Jonathan R. Young et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 51 citations · Full text

, , +6

A Potent, Nonpeptidyl 1<i>H</i>-Quinolone Antagonist for the Gonadotropin-Releasing Hormone Receptor

Robert J. DeVita, Thomas F. Walsh, Jonathan R. Young et al. · Journal of Medicinal Chemistry · 2001 · 47 citations · Full text

Synthesis and SAR of 5,6-diarylpyridines as human CB1 inverse agonists

Laura C. Meurer, Paul E. Finke, Sander G. Mills et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 33 citations · Full text

, , +9

Furo[2,3-b]pyridine-based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation. Part 1

John S. Debenham, Christina B. Madsen-Duggan, Richard B. Toupence et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 30 citations · Full text

, , +10

Rows per page

1–5 of 7